Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - Wikidata - awgldk - TriplyDB

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

http://www.wikidata.org/entity/Q56019470

about

Current imaging strategies for the evaluation of uterine cervical cancer Clinical practice recommendations for quality of life assessment in patients with gynecological cancer Role of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literature New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care Premenopausal abnormal uterine bleeding and risk of endometrial cancer The role of surgery in recurrent endometrial cancer.SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis.Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer.A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion Mistaken identity: endometrial or rectal cancer?Late metastatic endometrial carcinoma at the repair site of an abdominal wall incisional hernia.Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer.Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB Effect of mTOR inhibitors in nude mice with endometrial carcinoma and variable PTEN expression status.Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.Just how accurate are the major risk stratification systems for early-stage endometrial cancer?A clinically applicable molecular-based classification for endometrial cancers.Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinoma Are preoperative histology and MRI useful for classification of endometrial cancer risk?ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.Immunohistochemical characterisation of molecular subtypes in endometrial cancer.Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols.Performance of sentinel lymph node biopsy in high-risk endometrial cancer.Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.Recent and current Phase II clinical trials in endometrial cancer: review of the state of art.EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.Ultrasound in gynecological cancer: is it time for re-evaluation of its uses?Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma.Pathophysiology of heavy menstrual bleeding.Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.Endometrial cancer: Not your grandmother's cancer.Role of diffusion-weighted MRI in the differential diagnosis of endometrioid and non-endometrioid cancer of the uterus.The role of fulvestrant in endometrial cancer.Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.Endometrial cancer with congenital uterine anomalies: 3 case reports and a literature review.

P2860

Q26751279-76B84E5E-667E-41C7-908A-49B00E06C9DF Q26768706-7086BC06-22C0-46D5-AF46-F36764C8270B Q26851368-712B07E8-D12A-4713-B0F8-8197233AACB8 Q28078792-D57D35A1-2AC9-4448-8954-309CEE2A0B37 Q30244243-10CD171B-BB19-475E-A161-7686C5D22026 Q30249789-EE2583EA-9297-4745-A3E8-3729A9213326 Q33582882-40FBE72F-B4E5-4888-9FD0-9C1F9E067FB4 Q33648936-4932D31D-1F2C-4301-B7B6-B22FB49A3972 Q33683007-325A9FE9-6CAE-4E05-92D0-AE61EEA5E557 Q33691535-61F131F4-DD19-49F0-9AB4-9EFD17109791 Q33735364-DFE823EF-9B9A-49C3-9A14-EB0F9E329423 Q33755309-155C95E5-6595-4839-ABF7-F7B1D1F5CEBB Q33760587-543A2C35-0C3E-4AE9-A078-A7E7997F5AD6 Q34306540-327155A4-31B2-44F7-9990-06F3594FEC02 Q35121869-F626172C-EB0F-458A-BB2A-734FABB6D7C0 Q35125641-BD69BF14-CBA7-47BF-B751-79666117A35C Q35678721-948D2EF7-73DD-44EC-8DB5-243569185363 Q35863143-9A718C46-008B-49B3-B9BF-44413825572A Q35887472-22A69DD8-A589-4A5A-9B26-57384453B17C Q36080667-BE46E48B-B553-40CB-8165-BD551B8ECE5F Q36372293-CF48C076-64B7-4D50-A840-ED6847B994AC Q36493409-2D87C5AF-6320-4375-A8E9-D553D4C50032 Q36930125-583CA298-1E05-488D-BF3A-E54B32C35B35 Q37018155-B393177D-E89D-4FE2-989E-DC429302B7ED Q37086873-1BE2EF3C-1384-4BAD-8DF0-5FB3126DC9F2 Q37619708-67C9F1F5-A9E7-4ED0-AA48-AA4FDD9FD940 Q38203354-7E7E07CF-F690-4DF3-A7C4-D35666CD92D7 Q38476060-236D9E92-F96E-454A-B277-9C6883D187CB Q38484202-DF3FC1D0-02F6-4B7B-B0C4-7733B6C913BA Q38670417-8A20F251-7B95-49EC-AB78-F3F5D517CC78 Q38676700-8036F4A3-949F-4DDE-B14D-5F7EB5F11355 Q38679531-869EA732-3A20-4901-9240-C372E1CEC934 Q38705372-975AED40-7789-4B75-A5B4-8E1635B43998 Q38825241-09282B38-FEC2-48A8-AC87-42F5A0BA1C0E Q38852405-1AE1E805-49E2-4866-BC89-1572A56FA7B2 Q38963475-F4A08875-5C89-40BF-A5BB-8E772DFC8835 Q38970776-DE4B8866-86D3-403C-9AC1-1BFAD20C3A4D Q39036939-DFDC5948-7B6E-48CD-85DD-0E25C5CFEF69 Q39069570-4C86C76C-A78D-4607-9F92-A3FEA0252231 Q39101014-C01C5FDC-ACB6-46FE-8CE2-0E397C1A6991

P2860

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

http://www.wikidata.org/entity/Q56019470

description

im September 2013 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2013

@uk

name

Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up

@en

Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up

@nl

type

label

Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up

@en

Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up

@nl

prefLabel

Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up

@en

Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up

@nl

P1433

Q56019470-959A3717-C187-4791-84A4-86B1B13BFDC0

P1476

Q56019470-48D7B25A-267A-415A-868D-93BFD5E5A46C

P2093

Q56019470-1651163B-7A7A-489F-8FFC-ACE0028DB7CE

Q56019470-21EC0FA3-D6E6-4BE6-BCFA-FD5F7BF3DADA

Q56019470-2F5802AE-3F88-463B-BEBD-1DA539E3EC0C

Q56019470-5B0FEB86-51F8-4C41-8DD9-BB7E5431B128

Q56019470-60E3FF3F-2E38-4EA3-81C0-F48EF94F71F4

Q56019470-838E6BC8-5A83-4842-A4E1-EFA02255F9E1

Q56019470-A9F4DCB2-BBEB-4241-B1A5-8632A73062F1

P2860

Q56019470-10E621F3-1545-42DB-90F8-968F6085F2CD

Q56019470-13C89A5C-2177-4A8F-B03A-70B95BD9EC36

Q56019470-153BBBE0-4F70-4A11-99B8-FD4EB0B62B66

Q56019470-21A60D7F-6AD9-43A6-A42D-5DE202D8093C

Q56019470-25510EA2-6BF1-424A-B326-F482AA66F3C3

Q56019470-3460CD13-3A20-444D-8652-B67608C0CA31

Q56019470-3BC65467-3803-4587-AFDA-6E8D1E1F720F

Q56019470-449E12B7-DC7C-40AC-92E8-0A61FF9BDEAD

Q56019470-48AFE945-F59A-42AE-A074-3D20B8961984

Q56019470-57F9041E-7CE9-4705-BB48-86CA4E0D8022

P304

Q56019470-F884E2F2-0D1C-42AB-AE6E-86F8400A041B

P31

Q56019470-4FCF3C03-D9CB-49F6-98E7-D4F4D6DB419B

P3181

Q56019470-00de3804-477e-5a5d-0471-60f93d0b7856

P356

Q56019470-EC4890AE-5A59-4059-B0F0-4CE4FC45F297

P433

Q56019470-06105DAA-059B-4EDC-9314-FD4B7F935FEE

P478

Q56019470-A292BF20-CD87-4450-ADB3-605F1B525C36

P577

Q56019470-F52F7627-8BAC-4522-8939-B4BEF18BEB0D

P698

Q56019470-B56D737D-D913-4CEF-BCE3-29E9C962B1D1

P921

Q56019470-1f7e7206-72c0-446b-8884-3708ee033955

P3181

P356

P1433

Annals of Oncology

P1476

Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up

@en

P2093

A. Colombo

http://www.w3.org/2001/XMLSchema#string

C. Marini

http://www.w3.org/2001/XMLSchema#string

C. Sessa

http://www.w3.org/2001/XMLSchema#string

E. Preti

http://www.w3.org/2001/XMLSchema#string

F. Landoni

http://www.w3.org/2001/XMLSchema#string

N. Colombo

http://www.w3.org/2001/XMLSchema#string

S. Carinelli

http://www.w3.org/2001/XMLSchema#string

P2860

Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review.

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group.

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.

Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

P304

vi33-vi38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

24

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/ANNONC/MDT353

http://www.w3.org/2001/XMLSchema#string

P433

suppl 6

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24078661

http://www.w3.org/2001/XMLSchema#string

P921